Efficacy and safety of orexin receptor antagonist as premedication

Efficacy and safety of orexin receptor antagonist as premedication - Orexin receptor antagonist premedication

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019977

Enrollment

Registered

2015-11-30

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent surgery under general anesthesia

Interventions

Patient receive oral belsomra premedication before induction anesthesia.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients, ASA physical state of I-III, undergoing surgery with general anesthesia .

Exclusion criteria

Exclusion criteria: over ASA physical state of IV pregnancy patients under twenty year old Patient consent can not be obtained

Design outcomes

Primary

Measure	Time frame
Blood pressure, Herat rate, Pulse oximetry, Ramsey sedation score:RSS	—

Secondary

Measure	Time frame
visual analog scale postoperative nause and vomiting Patient satisfaction Safety of transport	—

Countries

Japan

Contacts

Public ContactNami Kakuta

Institute of Biomedical Sciences Tokushima University Graduate School Department of Anesthesiology

kakuta.nami@tokushima-u.ac.jp81-88-633-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026